News
May 20, 2022 News
Connect with us on LinkedIn
and follow our company updates
May 20, 2022 News
Oblique therapeutics AB förlänger teckningsperiod
i den påagående företrädesemissiomen av tvingande konvertibler
May 18, 2022 Event
Oblique Therapeutics AB (publ.) will be participating
to the BIO International Convention June 13-16, 2022・San Diego, CA
March 14, 2022 Event
Oblique Therapeutics AB (publ.) will be at the Pharma Partnering Summit
12th and 13th May 2022 - Brussels
March 7, 2022 Event
Thrilled to take part as Expert Speaker to the next DDN event
21st- 22nd April 2022- Philadelphia - USA
February 28, 2022 Event
Oblique Therapeutics AB (publ.) will be attending to BIO-Europe Spring 2022
online event from March 28th -31.
February 4, 2022 News
We are hiring- Laboratory Engineer
Location: Gothenburg
January 20, 2022 Event
Oblique Therapeutics AB (publ.)will join the BiotechGate Digital Partnering
7-11 Feb 2022.
January 14, 2022 News
Oblique Therapeutics AB (publ.) is pleased to announce that the United States Patent and Trademark Office
has granted a patent for its innovative AbiProt® technology
December 31, 2021 Event
Oblique’s Therapeutics AB (publ.) presentation at the virtual J.P. Morgan Healthcare Conference
scheduled for Monday, January 10, 2022